Cargando…

Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review

Brain metastasis from intrahepatic cholangiocarcinoma (iCCA) is extremely rare, and no standard therapeutic strategy has been established. Camrelizumab is a programmed cell death protein 1 (PD-1) inhibitor that has been widely studied in treating liver cancer. Combined immunotherapy and targeted the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Peiyi, Guo, Lei, Zhang, Bo, Xu, Yongfeng, Song, Qi, Shi, Hongcheng, Ye, Qinghai, Li, Hui, Xiao, Yongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382583/ https://www.ncbi.nlm.nih.gov/pubmed/35992782 http://dx.doi.org/10.3389/fonc.2022.911202

Ejemplares similares

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

Intrahepatic cholangiocarcinoma with gastric metastasis misdiagnosed as primary gastric cancer: A case report and literature review
por: Zhu, Qingshun, et al.
Publicado: (2022)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
por: Deng, Min, et al.
Publicado: (2022)

Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review
por: Sam Saji, Alen, et al.
Publicado: (2023)

Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma
por: Liang, Wenjie, et al.
Publicado: (2018)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
por: Fiste, Oraianthi, et al.
Publicado: (2021)

High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma
por: Zhang, Bo, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

Successful Resection of Solitary Abdominal Wall Metastasis of Sarcomatous Intrahepatic Cholangiocarcinoma
por: Ono, Kosuke, et al.
Publicado: (2019)

A Successfully Treated Case of Intrahepatic Cholangiocarcinoma with Exacerbation of Dermatomyositis
por: Yasuda, Jungo, et al.
Publicado: (2018)

Laparoscopic or open liver resection for intrahepatic cholangiocarcinoma: A meta-analysis and systematic review
por: Zhao, Xin, et al.
Publicado: (2023)

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma
por: Zhang, Bo, et al.
Publicado: (2020)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Radiation Recall in a Patient with Intrahepatic Cholangiocarcinoma: Case Report and a Literature Review
por: Bahaj, Waled, et al.
Publicado: (2019)

Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
por: Gao, Yang, et al.
Publicado: (2021)

Sarcomatoid Intrahepatic Cholangiocarcinoma After Immunotherapy: A Case Report and Review of the Literature
por: Zeng, Zheng, et al.
Publicado: (2022)

Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma
por: Xu, Lin, et al.
Publicado: (2021)

Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma
por: Li, Hui, et al.
Publicado: (2021)

A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case
por: Fu, Qiang, et al.
Publicado: (2022)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers
por: Connor, Ashton A., et al.
Publicado: (2022)

Proposal for a new N-stage classification system for intrahepatic cholangiocarcinoma
por: Liao, Shan, et al.
Publicado: (2023)

Dramatic response and acquired resistance to savolitinib in advanced intrahepatic cholangiocarcinoma with MET amplification: a case report and literature review
por: Zhou, Kexun, et al.
Publicado: (2023)

Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription
por: Xia, Long, et al.
Publicado: (2021)

Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis, Nikolaos, et al.
Publicado: (2021)

Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From China
por: Ke, Qiao, et al.
Publicado: (2021)

The causal relationship between metabolic factors, drinking, smoking and intrahepatic cholangiocarcinoma: a Mendelian randomization study
por: Qin, Shan-shan, et al.
Publicado: (2023)

Radiotherapy combined with immunotherapy successfully treated one case of anaplastic thyroid cancer: A case report
por: Xing, Yurou, et al.
Publicado: (2023)

Successful treatment of colorectal liver metastasis harboring intrahepatic cholangiocarcinoma: A case report
por: Cheng, Xiaofei, et al.
Publicado: (2018)

Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass
por: Xue, Beihui, et al.
Publicado: (2021)

Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma
por: Rong, Zhuo-Xian, et al.
Publicado: (2019)

Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma
por: Yang, Hua, et al.
Publicado: (2019)

Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
por: Massa, Annamaria, et al.
Publicado: (2022)

Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend
por: Chen, Pengyu, et al.
Publicado: (2023)

Skull Metastasis From Intrahepatic Cholangiocarcinoma: Report of 3 Cases and Review of the Literature
por: Fujimoto, Kenji, et al.
Publicado: (2013)

Latent Risk Intrahepatic Cholangiocarcinoma Susceptible to Adjuvant Treatment After Resection: A Clinical Deep Learning Approach
por: Jeong, Seogsong, et al.
Publicado: (2020)

A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data
por: Li, Zhizhen, et al.
Publicado: (2021)

Low expression and Hypermethylation of ATP2B1 in Intrahepatic Cholangiocarcinoma Correlated With Cold Tumor Microenvironment
por: Zhang, Xiehua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s9qq5vp0gu3qihjvfmpv53gqk8